Editorial Office
Editor-in-Chief
Prof. Dr. Diane M. Harper
Professor of Medicine, Director of Gynecologic Cancer Prevention Research Group, Center of Excellence in Women's Health, University of Missouri-Kansas City School of Medicine, 2301 Holmes Street, Kansas City MO 64108 USA
Tel. +1 603 650 6355; Fax: +1 603 650 6333
E-Mail: diane.m.harper@gmail.com
Interests: cervical cancer prevention; HPV vaccine, HPV prevention; HPV cure; CIN detection; CIN cure; Quality of Life; Shared Decision Making; Communications
Assistant Editor
Ms. Xinya Huang
MDPI Beijing Office, Suite 2011, Ruidu International Center, No. 1 Cuijingbeili, Tongzhou District, Beijing, China
Tel. +86 10 81521170
E-Mail: xinya.huang@mdpi.com
Publisher
Dr. Shu-Kun Lin
MDPI AG, Kandererstrasse 25, CH-4057 Basel, Switzerland
Tel. +41 79 322 33 79
Website: http://www.mdpi.org/lin/
E-Mail: lin@mdpi.com
Editorial Board
Prof. Dr. Pedro L. Alonso
Barcelona Center for International Health Research(CRESIB), Hospital Clinic/IDIBAPS, University of Barcelona, Villarroel 170, 08036 Barcelona, Spain
Tel. +34 93 227 5706; Fax: +34 93 227 9853
Website: http://www.cresib.cat/en/page.asp?id=80
E-Mail: palonso@clinic.ub.es
Interests: public health; host-pathogen interaction; Malaria; viral and bacterial infections; HIV/AIDS and STI’s
Dr. Rolf Billeskov
Department of Infectious Disease Immunology, Division of Vaccine, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmark Institute of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
Tel. +45 3268 8144; Fax: +45 3268 3035
Website: http://www.ssi.dk/Service/Kontakt/Medarbejdere/Person.aspx?id=033b5599-9106-4ae9-b31a-9d8800afa838
E-Mail: ROB@ssi.dk
Interests: immunology; T cells; tuberculosis; polyfunctionality of T cells; T cell avidity; vaccines
Dr. Joseph E. Blaney, Jr.
Emerging Viral Pathogens Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 8200 Research Plaza, Room 1A-124, Fort Detrick, MD 21702, USA
Tel. +1 301 631 7211; Fax: +1 301 631 7387
E-Mail: JBLANEY@niaid.nih.gov
Interests: Viral vaccines, pathogenesis of emerging viruses, biodefense, animal model development
Prof. Dr. Thierry Boon
de Duve Institute, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels Branch, 74 av. Hippocrate, UCL7459, B-1200 Brussels, Belgium
Tel. +32 (0)2764 7450; Fax: +32 (0)2762 9405
Website: http://www.bru.licr.org/brussels/research/iman/iman.html
E-Mail: thierry.boon@bru.licr.org
Interests: The work of our group is aimed at understanding why some metastatic melanoma patients show tumor regression following vaccination whereas most patients do not. Recent results suggest that a local immunosuppressive environment at the tumor sites may be the main barrier to the efficacy of immunotherapy.
Prof. Dr. Olga Borges
Center for Neuroscience and Cell Biology & Faculty of Pharmacy, University of Coimbra, Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal
Tel. +351 239 488 428
Website: http://www.cnbc.pt/
E-Mail: olga@ci.uc.pt
Interests: focussed on the development of polymeric carriers as adjuvants for mucosal vaccination (protein and DNA) and examination of the interactions of delivery systems with biological targets in vitro and in vivo
Dr. Sandra S. Chaves
Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30333, USA
Tel. + 1 404 639 2797; Fax: +1 404 929 2729
E-Mail: Schaves@cdc.gov
Interests: infectious disease epidemiology; influenza; duration of vaccine-induced immunity; influenza treatment; influenza prevention
Dr. Genoveffa Franchini
Animal Models & Retroviral Vaccine Section, Vaccine Branch, National Cancer Institute, National Institute of Health, 9000 Rockville Pike, Bethesda MD, 20892, USA
Tel. +1 301 496 2386; Fax: +1 301 402 0055
Website: http://ccr.cancer.gov/staff/staff.asp?Name=franchini
E-Mail: franchig@mail.nih.gov
Interests: immunology, virology, vaccines; HTLV; SIV; animal models; vaccine development
Prof. Dr. Eli Gilboa
Department of Microbiology and Immunology, Dodson Interdisciplinary Immunotherapy Institute and the Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, 1550 NW 10th Avenue, Room 211, Papanicolaou Cancer Research Building, Miami, FL 33136, USA
Tel. +1 305 243 1767; Fax: +1 305 243 4409
Website: http://biomed.miami.edu/?p=482&pid=206&m=facultyph&mid=1&item=200
E-Mail: egilboa@med.miami.edu
Interests: My laboratory is using murine tumor models to develop a multi-pronged strategy to elicit clinically-useful antitumor immune responses in cancer patients. The current main strategy is to develop immune modulatory agents composed of short oligonucleotides (siRNAs, aptamers, antagomirs) that are targeted to the tumor or the tumor-activated immune system by conjugation to oligonucleotide aptamer ligands
Prof. Dr. Marc P. Girard
University Paris 7, French National Academy of Medicine, 49 rue D'Aubigny, FR 69003 Lyon, France
Tel. +33 680 237 682
Website: http://www.mymetics.com/company/scientific-advisory-board/dr-marc-girard
E-Mail: marc.girard36@wanadoo.fr
Interests: viral vaccine research and development: HIV vaccines, influenza vaccines, lentiviruses; vaccinology in general; and anti-viral immune responses: neutralizing antibodies, ADCC and ADCVI, CD8+ T cell responses, innate immunity responses, mucosal immunity
Dr. Elena A. Govorkova
Department of Infectious Diseases, St. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA
Tel. +1 901 595 2243; Fax: +1 901 595 8559
Website: http://www.stjuderesearch.org/site/authors/govorkova
E-Mail: elena.govorkova@stjude.org
Interests: antiviral drugs for the control of influenza infection, including H5N1 influenza viruses: assessment of antiviral drug efficacy in vitro and in vivo; evaluation of viral fitness; combination chemotherapy; influenza vaccines: immunogenicity and protective efficacy
Dr. Guido Grandi
Novartis Vaccines and Diagnostics, Research Center, Via Fiorentina 1, 53100 Siena, Italy
Tel. +39 0577 243506; Fax: +39 0577 278514
E-Mail: guido.grandi@novartis.com
Interests: bacterial infectious diseases; group A streptococcus; group B streptococcus; S. aureus; Chlamydia; vaccine development; proteomics; genomics; high throughput technologies
Prof. Dr. Chinnaswamy Jagannath
Department of Pathology and Laboratory Medicine, University of Texas Health Sciences Center, 6400 Fannin Street, MSB 2.200, Houston, TX 77030, USA
Tel. +1 713 500 5353
Website: http://www.uthouston.edu/gsbs/faculty/faculty-directory/faculty-profiles.htm?id=1346243
E-Mail: Chinnaswamy.Jagannath@uth.tmc.edu
Interests: vaccines for tuberculosis; TLR signaling and adjuvants; Th1 immunity and T cells; Dendritic cells and macrophages-pathogen survival
Contribution:
Special Issue: Tuberculosis Vaccines
Dr. Aisha O. Jumaan
TEPHNET-Centers for Disease Control and Prevention, 3216 74th Place SE. Mercer Island, WA 98040, USA
Tel. +1 404 432 8861
E-Mail: aoj1@cdc.gov
Interests: vaccines; vaccine preventable diseases; vaccine effectiveness; infectious diseases; breast and cervical cancers; maternal and child health
Prof. Dr. Matti Osmo Antero Lehtinen
School of Health Sciences, University of Tampere, Sorinkatu 1, 33014 Tampere, Finland
Tel. +358 40 5437862; Fax: +358 3 35518057
Website: http://www.rokotiitus.net/
E-Mail: Matti.Lehtinen@uta.fi
Interests: cancer; tumor viruses; immune response; infectious disease epidemiology; sexually transmitted infections; translational medicine
Prof. Dr. Margaret A. Liu
1 ProTherImmune, 3656 Happy Valley Road Lafayette, CA 94549, USA 2 Karolinska Institute, Stockholm SE-17177, Sweden
Tel. +1 925 299 2959; Fax: +1 925 299 2959
Website: http://ki.se/ki/jsp/polopoly.jsp?d=23327&a=36147&l=en
E-Mail: liu@protherimmune.com
Interests: vaccine technologies; DNA vaccines; cellular immune responses; HIV Vvccines; global health
Contribution:
Special Issue: DNA Vaccines
Prof. Dr. Abu Salim Mustafa
Department of Microbiology, Faculty of Medicine, Kuwait University PO Box 24923, Safat 13110, Kuwait
Tel. +965 24896505; Fax: +965 25332719
Website: http://www.hsc.edu.kw/services/staff_PDF/abusalim.pdf
E-Mail: abusalim@hsc.edu.kw
Interests: Tuberculosis; vaccines; immunodiagnosis; immuno-pathogenesis
Contribution:
Special Issue: Tuberculosis Vaccines
Prof. Dr. Toshi Nagata
Department of Health Science, Hamamatsu University School of Medicine, 1-20-1 Handa-yama, Higashi-ku, Hamamatsu 431-3192, Japan
Tel. +81 53 435 2332
E-Mail: tnagata@hama-med.ac.jp
Interests: intracellular bacteria; T cell responses; DNA vaccines; HLA; antigen presentation; tuberculosis
Prof. Dr. Sven-Eric Olsson
Karolinska Institute at Danderyd Hospital, SE-182 88 Stockholm, Sweden
Tel. +46 8655 5608; Fax: +46 8753 2276
E-Mail: sven-eric.olsson@ds.se
Interests: HPV vaccines; dysplasias and treatment options; immunological memory; cervical cancer screeningHPV vaccines; dysplasias and treatment options; immunological memory; cervical cancer screening programmes programmes
Dr. Mark Pearson
Queensland Tropical Health Alliance, James Cook University, Cairns, Queensland 4878, Australia
Tel. +61 7 40421865; Fax: +44 7 40421492
Website: http://www.jcu.edu.au/phtmrs/abc/staff/JCU_078568.html
E-Mail: mark.pearson@jcu.edu.au
Interests: Mark’s major research focus involves looking at the functions of proteins from human parasites (specifically helminths, or worms) and how these molecules interact with the host immune system.I am particularly interested in understanding these processes in the context of developing vaccines against parasites of third world populations and finding novel therapies for autoimmune disorders such as asthma
Prof. Dr. Barbara Romanowski
Department of Medical Microbiology and Immunology, University of Alberta, Suite 1000 College Plaza, 8215 112 Street, Edmonton, Alberta, T6G 2C8, Canada
Tel. +780 436 4900; Fax: +780 436 4920
E-Mail: broman@docromanowski.com
Interests: HPV infection; HPV vaccination; sexually transmitted diseases; HIV; vaginitis
Prof. Dr. John K. Rose
Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA
Tel. +1 203 785 6184; Fax: +1 203 785 7467
Website: http://virology.yale.edu/people/john_rose-3.profile
E-Mail: john.rose@yale.edu
Interests: virology; vaccine and gene expression vectors based on rhabdoviruses; membrane protein assembly, transport and targeting; viral assembly
Dr. Daniel A. Salmon
Johns Hopkins School of Hygiene and Public Health, 615 N. Wolfe St., Ste. 5515, Baltimore, MD 21205, USA
Tel. +1 443 803 7754
Website: http://www.jhsph.edu/faculty/directory/profile/3934/Salmon/Daniel
E-Mail: dsalmon@jhsph.edu
Interests: optimizing the prevention of childhood infectious diseases through the use of vaccines
Contribution:
Special Issue: Confidence in Vaccines
In other journals:
Special Issue: Vaccine Safety and Public Health
Prof. Dr. Pramod K. Srivastava
Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, CT 06030-1601, USA
Tel. +1 860 679 4444; Fax: +1 860 679 7905
Website: http://immune.uchc.edu/faculty_research/faculty_profiles/srivastava.html
E-Mail: srivastava@uchc.edu
Interests: antigen presentation by MHC I and MHC II molecules; immune response to cancer; viral immunity and autoimmunity
Dr. Stanley S. Tai
Department of Microbiology, College of Medicine, Howard University, 520 “W” Street, NW, Washington, DC 20059, USA
Tel. +1 202 806 4677; Fax: +1 202 667 9589
E-Mail: stai@howard.edu
Interests: pneumococcal vaccine; respiratory bacterial pathogens; bacterial pathogenesis
Contribution:
Special Issue: Pneumococcal Vaccine in the 21st Century
Prof. Dr. Sjoerd H. van der Burg
Department of Oncology, Section Experimental Cancer Immunology and Therapy, K1-P, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
Tel. +31 526 1180
Website: http://www.lumc.nl/con/3060/83287/105430/100420005904334/
E-Mail: shvdburg@lumc.nl
Interests: The aim of my laboratory is to optimally implement immunotherapy as treatment modality for patients with solid tumors. The program is focused on the exploration of key factors in host-tumor interactions that determine successes and failures in immune control of cancer in order to drive the improvement of our immunotherapeutic strategies against solid tumors. Keywords: therapeutic vaccines, immunotherapy, peptides, HPV, chronic viral infections, cancer
Prof. Dr. Zhou Xing
McMaster Immunology Research Centre, Department of Pathology & Molecular Medicine, Rm. MDCL-4012, McMaster University, 1280 Main St. West, Hamilton, Ontario L8S 4K1, Canada
Tel. +1 905 525 9140 ext. 22354; Fax: +1 905 522 6750
Website: http://fhs.mcmaster.ca/pathology/contact_us/faculty/faculty_bios/xing.html
E-Mail: xingz@mcmaster.ca
Interests: infectious diseases; pulmonary infectious disease; T cell immunity; vaccines; mucosal vaccination
Dr. Shi-Yu Yang
Division of Surgery & Interventional Science, University College London, Rowland Hill Street, London, NW3 2PF, UK
Website: http://www.ucl.ac.uk/ucl-iris-project/iris/staffprofile.php?ref=SYANG44
E-Mail: shiyu.yang@ucl.ac.uk
Interests: colorectal cancer, stem cells; regenerative medicine
|
